Delivery Order SPE2DR25D2005-SPE2DR26FF0Q5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,832.33 to supply Trulicity 0.75 mg/0.5 ml pens. This competitive, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and represents a continuation of the company's pharmaceutical supply services supporting federal military and veteran healthcare systems. The award carries no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) valued at $8,597.36 for Trulicity 1.5 mg/0.5 ml pens (0.5 ml vials). The award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 17, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injectors valued at $2,180.55. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 18, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is funded by the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,453.41 on December 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of December 16, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and is funded by the Defense Logistics Agency (DLA), a defense agency component of the Department of Defense. The award represents...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF0Q5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,260.00 by the Defense Logistics Agency on January 12, 2026, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was awarded without a set-aside designation through competitive procurement. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery of Trulicity, a diabetes medication, fulfills critical pharmaceutical supply needs for military treatment facilities and veterans' healthcare programs administered through the Defense Health Agency and other federal medical institutions. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to meet government procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The performance location for this order is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/11/26 |